David A Ramsay - Insider Trading Tracker

Halozyme 治疗公司

US ˙ NasdaqGS ˙ US40637H1095

介绍

本页面提供了有关 David A Ramsay 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。

报告内部持仓的公司

美国证券交易委员会（SEC）文件显示David A Ramsay已报告在以下公司拥有持仓或进行了交易：

证券	职位	最新报告的持仓
US:SVRA / Savara Inc.	Director	2,513,642
US:LJPC / La Jolla Pharmaceutical Co.	Director	0
US:HALO / Halozyme Therapeutics, Inc.	VP and Chief Financial Officer	21,262

如何解读这些图表

以下图表显示了在David A Ramsay进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

HALO / Halozyme Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 HALO / Halozyme Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	股票代码	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最高利润的天数	达到最高利润时的价格	最高利润($)	最高回报率（%）
2014-09-16	HALO	RAMSAY DAVID A	25,000	8.9000	25,000	8.9000	222,500	309	24.7500	396,250	178.09

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

HALO / Halozyme Therapeutics, Inc. Insider Trades

HALO / Halozyme Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 HALO / Halozyme Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	股票代码	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最低利润的天数	达到最低利润时的价格	避免的最高损失金额($)	避免的最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF内部人士买入 - 短期收益分析

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	股票代码	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最高利润的天数	达到最高利润时的价格	最高利润($)	最高回报率（%）
2025-03-31	SVRA	RAMSAY DAVID A	150,000	2.7750	150,000	2.7750	416,250	161	3.8500	161,250	38.74
2024-11-18	SVRA	RAMSAY DAVID A	100,000	2.8760	100,000	2.8760	287,600
2023-05-26	SVRA	RAMSAY DAVID A	37,124	2.6290	37,124	2.6290	97,599
2023-05-25	SVRA	RAMSAY DAVID A	12,876	2.5730	12,876	2.5730	33,130
2023-05-24	SVRA	RAMSAY DAVID A	50,000	2.5560	50,000	2.5560	127,800
2022-12-30	SVRA	RAMSAY DAVID A	29,000	1.5460	29,000	1.5460	44,834
2022-12-29	SVRA	RAMSAY DAVID A	7,000	1.5360	7,000	1.5360	10,752
2022-12-28	SVRA	RAMSAY DAVID A	3,293	1.4950	3,293	1.4950	4,923
2022-12-23	SVRA	RAMSAY DAVID A	15,707	1.4430	15,707	1.4430	22,665
2022-12-22	SVRA	RAMSAY DAVID A	41,414	1.4760	41,414	1.4760	61,127
2022-12-20	SVRA	RAMSAY DAVID A	13,830	1.5010	13,830	1.5010	20,759
2022-12-20	SVRA	RAMSAY DAVID A	3,586	1.4800	3,586	1.4800	5,307
2022-12-19	SVRA	RAMSAY DAVID A	40,719	1.4940	40,719	1.4940	60,834
2022-12-16	SVRA	RAMSAY DAVID A	341	1.5000	341	1.5000	512
2022-11-23	SVRA	RAMSAY DAVID A	4,610	1.4390	4,610	1.4390	6,634
2022-11-22	SVRA	RAMSAY DAVID A	15,495	1.4210	15,495	1.4210	22,018
2022-11-21	SVRA	RAMSAY DAVID A	25,005	1.4210	25,005	1.4210	35,532
2022-11-18	SVRA	RAMSAY DAVID A	16,100	1.3420	16,100	1.3420	21,606
2022-11-17	SVRA	RAMSAY DAVID A	8,900	1.2700	8,900	1.2700	11,303
2022-09-27	SVRA	RAMSAY DAVID A	73,893	1.3720	73,893	1.3720	101,381
2022-09-26	SVRA	RAMSAY DAVID A	31,107	1.3840	31,107	1.3840	43,052
2022-09-23	SVRA	RAMSAY DAVID A	30,000	1.4220	30,000	1.4220	42,660
2022-09-20	SVRA	RAMSAY DAVID A	600	1.4500	600	1.4500	870
2022-09-19	SVRA	RAMSAY DAVID A	1,400	1.4570	1,400	1.4570	2,040
2022-09-16	SVRA	RAMSAY DAVID A	6,000	1.4420	6,000	1.4420	8,652
2022-09-08	SVRA	RAMSAY DAVID A	29,000	1.3990	29,000	1.3990	40,571
2022-09-07	SVRA	RAMSAY DAVID A	2,130	1.3850	2,130	1.3850	2,950
2022-09-06	SVRA	RAMSAY DAVID A	870	1.3800	870	1.3800	1,201
2022-09-01	SVRA	RAMSAY DAVID A	39,768	1.4200	39,768	1.4200	56,471
2022-08-31	SVRA	RAMSAY DAVID A	39,494	1.4230	39,494	1.4230	56,200
2022-08-30	SVRA	RAMSAY DAVID A	20,738	1.4110	20,738	1.4110	29,261
2022-06-22	SVRA	RAMSAY DAVID A	39,000	1.4450	39,000	1.4450	56,355
2022-06-21	SVRA	RAMSAY DAVID A	21,094	1.3800	21,094	1.3800	29,110
2022-06-17	SVRA	RAMSAY DAVID A	39,906	1.3260	39,906	1.3260	52,915
2021-12-30	SVRA	RAMSAY DAVID A	35,000	1.2960	35,000	1.2960	45,360
2021-12-29	SVRA	RAMSAY DAVID A	15,000	1.2450	15,000	1.2450	18,675
2021-12-17	SVRA	RAMSAY DAVID A	25,000	1.1290	25,000	1.1290	28,225
2021-12-15	SVRA	RAMSAY DAVID A	15,000	1.0840	15,000	1.0840	16,260
2021-12-10	SVRA	RAMSAY DAVID A	35,000	1.0390	35,000	1.0390	36,365
2021-12-08	SVRA	RAMSAY DAVID A	13,157	1.0500	13,157	1.0500	13,815
2021-12-07	SVRA	RAMSAY DAVID A	11,843	1.0470	11,843	1.0470	12,400
2021-12-02	SVRA	RAMSAY DAVID A	21,394	1.0860	21,394	1.0860	23,234
2021-12-01	SVRA	RAMSAY DAVID A	9,000	1.0850	9,000	1.0850	9,765
2021-12-01	SVRA	RAMSAY DAVID A	3,606	1.0800	3,606	1.0800	3,894
2021-11-30	SVRA	RAMSAY DAVID A	16,000	1.0870	16,000	1.0870	17,392
2021-11-22	SVRA	RAMSAY DAVID A	90,000	1.0780	90,000	1.0780	97,020
2021-11-19	SVRA	RAMSAY DAVID A	49,800	1.0690	49,800	1.0690	53,236
2021-11-18	SVRA	RAMSAY DAVID A	60,200	1.0820	60,200	1.0820	65,136
2021-09-30	SVRA	RAMSAY DAVID A	50,000	1.2980	50,000	1.2980	64,900
2021-09-29	SVRA	RAMSAY DAVID A	47,500	1.2770	47,500	1.2770	60,658
2021-09-28	SVRA	RAMSAY DAVID A	39,552	1.2850	39,552	1.2850	50,824
2021-08-18	SVRA	RAMSAY DAVID A	12,948	1.1800	12,948	1.1800	15,279
2021-08-18	SVRA	RAMSAY DAVID A	17,788	1.2200	17,788	1.2200	21,701
2021-08-17	SVRA	RAMSAY DAVID A	66,554	1.1750	66,554	1.1750	78,201
2021-05-19	SVRA	RAMSAY DAVID A	5,003	1.5800	5,003	1.5800	7,905
2021-05-18	SVRA	RAMSAY DAVID A	50,000	1.6220	50,000	1.6220	81,100
2021-03-15	SVRA	RAMSAY DAVID A	689,655	1.4500	689,655	1.4500	1,000,000
2019-06-28	SVRA	RAMSAY DAVID A	18,000	2.3300	18,000	2.3300	41,940
2019-06-28	SVRA	RAMSAY DAVID A	12,157	2.3500	12,157	2.3500	28,569
2019-06-28	SVRA	RAMSAY DAVID A	5,000	2.3600	5,000	2.3600	11,800
2019-06-27	SVRA	RAMSAY DAVID A	5,000	2.4500	5,000	2.4500	12,250
2019-06-27	SVRA	RAMSAY DAVID A	5,000	2.4200	5,000	2.4200	12,100
2019-06-27	SVRA	RAMSAY DAVID A	5,000	2.4000	5,000	2.4000	12,000
2019-06-27	SVRA	RAMSAY DAVID A	5,000	2.3900	5,000	2.3900	11,950
2019-06-27	SVRA	RAMSAY DAVID A	2,300	2.3800	2,300	2.3800	5,474
2019-06-26	SVRA	RAMSAY DAVID A	900	2.3800	900	2.3800	2,142
2019-06-18	SVRA	RAMSAY DAVID A	5,000	2.3600	5,000	2.3600	11,800
2019-06-18	SVRA	RAMSAY DAVID A	10,215	2.3500	10,215	2.3500	24,005
2019-06-17	SVRA	RAMSAY DAVID A	10,000	2.3900	10,000	2.3900	23,900
2019-06-17	SVRA	RAMSAY DAVID A	10,000	2.3800	10,000	2.3800	23,800
2019-06-17	SVRA	RAMSAY DAVID A	5,000	2.3700	5,000	2.3700	11,850
2017-06-07	SVRA	RAMSAY DAVID A	21,000	4.7500	21,000	4.7500	99,750
2012-05-14	ANX	RAMSAY DAVID A	50,000	0.5393	50,000	0.5393	26,965
2012-05-10	ANX	RAMSAY DAVID A	40,000	0.5653	40,000	0.5653	22,612
2012-05-09	ANX	RAMSAY DAVID A	10,000	0.5500	10,000	0.5500	5,500

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Insider Trades

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF内部人士卖出 - 短期亏损分析

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	股票代码	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最低利润的天数	达到最低利润时的价格	避免的最高损失金额($)	避免的最高损失率($)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

内幕交易历史

该表格显示了由 David A Ramsay 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期	交易日期	表格	股票代码	证券	代码	股数	剩余股数	% 变化	每股股价	交易金额	剩余金额
2025-04-01	2025-03-31	4	SVRA	Savara Inc Common Stock	P - Purchase	150,000	2,513,642	6.35	2.78	416,250	6,975,357
2024-12-16	2024-12-12	4	SVRA	Savara Inc Common Stock	A - Award	40,000	2,363,642	1.72
2024-11-18	2024-11-18	4	SVRA	Savara Inc Common Stock	P - Purchase	100,000	2,323,642	4.50	2.88	287,600	6,682,794
2023-12-15	2023-12-14	4	SVRA	Savara Inc Common Stock	A - Award	22,500	2,223,642	1.02
2023-05-26	2023-05-26	4	SVRA	Savara Inc Common Stock	P - Purchase	37,124	2,201,142	1.72	2.63	97,599	5,786,802
2023-05-26	2023-05-25	4	SVRA	Savara Inc Common Stock	P - Purchase	12,876	2,164,018	0.60	2.57	33,130	5,568,018
2023-05-26	2023-05-24	4	SVRA	Savara Inc Common Stock	P - Purchase	50,000	2,151,142	2.38	2.56	127,800	5,498,319
2023-01-03	2022-12-30	4	SVRA	Savara Inc Common Stock	P - Purchase	29,000	2,101,142	1.40	1.55	44,834	3,248,366
2023-01-03	2022-12-29	4	SVRA	Savara Inc Common Stock	P - Purchase	7,000	2,072,142	0.34	1.54	10,752	3,182,810
2022-12-28	2022-12-28	4	SVRA	Savara Inc Common Stock	P - Purchase	3,293	2,065,142	0.16	1.50	4,923	3,087,387
2022-12-28	2022-12-23	4	SVRA	Savara Inc Common Stock	P - Purchase	15,707	2,061,849	0.77	1.44	22,665	2,975,248
2022-12-22	2022-12-22	4	SVRA	Savara Inc Common Stock	P - Purchase	41,414	2,046,142	2.07	1.48	61,127	3,020,106
2022-12-22	2022-12-20	4	SVRA	Savara Inc Common Stock	P - Purchase	3,586	2,004,728	0.18	1.48	5,307	2,966,997
2022-12-20	2022-12-20	4	SVRA	Savara Inc Common Stock	P - Purchase	13,830	2,001,142	0.70	1.50	20,759	3,003,714
2022-12-20	2022-12-19	4	SVRA	Savara Inc Common Stock	P - Purchase	40,719	1,987,312	2.09	1.49	60,834	2,969,044
2022-12-20	2022-12-16	4	SVRA	Savara Inc Common Stock	P - Purchase	341	1,946,593	0.02	1.50	512	2,919,890
2022-11-25	2022-11-23	4	SVRA	Savara Inc Common Stock	P - Purchase	4,610	1,946,252	0.24	1.44	6,634	2,800,657
2022-11-25	2022-11-22	4	SVRA	Savara Inc Common Stock	P - Purchase	15,495	1,941,642	0.80	1.42	22,018	2,759,073
2022-11-21	2022-11-21	4	SVRA	Savara Inc Common Stock	P - Purchase	25,005	1,926,147	1.32	1.42	35,532	2,737,055
2022-11-21	2022-11-18	4	SVRA	Savara Inc Common Stock	P - Purchase	16,100	1,901,142	0.85	1.34	21,606	2,551,333
2022-11-21	2022-11-17	4	SVRA	Savara Inc Common Stock	P - Purchase	8,900	1,885,042	0.47	1.27	11,303	2,394,003
2022-09-27	2022-09-27	4	SVRA	Savara Inc Common Stock	P - Purchase	73,893	1,876,142	4.10	1.37	101,381	2,574,067
2022-09-27	2022-09-26	4	SVRA	Savara Inc Common Stock	P - Purchase	31,107	1,802,249	1.76	1.38	43,052	2,494,313
2022-09-27	2022-09-23	4	SVRA	Savara Inc Common Stock	P - Purchase	30,000	1,771,142	1.72	1.42	42,660	2,518,564
2022-09-20	2022-09-20	4	SVRA	Savara Inc Common Stock	P - Purchase	600	1,741,142	0.03	1.45	870	2,524,656
2022-09-20	2022-09-19	4	SVRA	Savara Inc Common Stock	P - Purchase	1,400	1,740,542	0.08	1.46	2,040	2,535,970
2022-09-20	2022-09-16	4	SVRA	Savara Inc Common Stock	P - Purchase	6,000	1,739,142	0.35	1.44	8,652	2,507,843
2022-09-08	2022-09-08	4	SVRA	Savara Inc Common Stock	P - Purchase	29,000	1,733,142	1.70	1.40	40,571	2,424,666
2022-09-08	2022-09-07	4	SVRA	Savara Inc Common Stock	P - Purchase	2,130	1,704,142	0.13	1.38	2,950	2,360,237
2022-09-08	2022-09-06	4	SVRA	Savara Inc Common Stock	P - Purchase	870	1,702,012	0.05	1.38	1,201	2,348,777
2022-09-01	2022-09-01	4	SVRA	Savara Inc Common Stock	P - Purchase	39,768	1,701,142	2.39	1.42	56,471	2,415,622
2022-09-01	2022-08-31	4	SVRA	Savara Inc Common Stock	P - Purchase	39,494	1,661,374	2.44	1.42	56,200	2,364,135
2022-09-01	2022-08-30	4	SVRA	Savara Inc Common Stock	P - Purchase	20,738	1,621,880	1.30	1.41	29,261	2,288,473
2022-08-24	2022-08-22	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	D - Sale to Issuer	-100,000	0	-100.00	6.23	-623,000
2022-06-22	2022-06-22	4	SVRA	Savara Inc Common Stock	P - Purchase	39,000	1,601,142	2.50	1.44	56,355	2,313,650
2022-06-22	2022-06-21	4	SVRA	Savara Inc Common Stock	P - Purchase	21,094	1,562,142	1.37	1.38	29,110	2,155,756
2022-06-22	2022-06-17	4	SVRA	Savara Inc Common Stock	P - Purchase	39,906	1,541,048	2.66	1.33	52,915	2,043,430
2022-01-14	2022-01-12	4	LJPC	LA JOLLA PHARMACEUTICAL CO Stock Option (Right to Buy)	A - Award	30,000	30,000
2021-12-30	2021-12-30	4	SVRA	Savara Inc Common Stock	P - Purchase	35,000	1,501,142	2.39	1.30	45,360	1,945,480
2021-12-30	2021-12-29	4	SVRA	Savara Inc Common Stock	P - Purchase	15,000	1,466,142	1.03	1.24	18,675	1,825,347
2021-12-17	2021-12-17	4	SVRA	Savara Inc Common Stock	P - Purchase	25,000	1,451,142	1.75	1.13	28,225	1,638,339
2021-12-17	2021-12-15	4	SVRA	Savara Inc Common Stock	P - Purchase	15,000	1,426,142	1.06	1.08	16,260	1,545,938
2021-12-14	2021-12-14	4	SVRA	Savara Inc Stock Option (Right to Buy)	A - Award	40,000	40,000
2021-12-13	2021-12-10	4	SVRA	Savara Inc Common Stock	P - Purchase	35,000	1,411,142	2.54	1.04	36,365	1,466,177
2021-12-09	2021-12-08	4	SVRA	Savara Inc Common Stock	P - Purchase	13,157	1,376,142	0.97	1.05	13,815	1,444,949
2021-12-09	2021-12-07	4	SVRA	Savara Inc Common Stock	P - Purchase	11,843	1,362,985	0.88	1.05	12,400	1,427,045
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	3,000	100,000	3.09	3.87	11,610	387,000
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	97,000	1.04	3.84	3,840	372,480
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,215	96,000	2.36	3.82	8,461	366,720
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	93,785	1.08	3.81	3,810	357,321
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	92,785	1.09	3.80	3,800	352,583
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	785	91,785	0.86	3.77	2,959	346,029
2021-12-06	2021-12-06	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	91,000	1.11	3.75	3,750	341,250
2021-12-06	2021-12-03	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	90,000	1.12	3.69	3,690	332,100
2021-12-06	2021-12-03	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	89,000	1.14	3.68	3,680	327,520
2021-12-06	2021-12-03	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	399	88,000	0.46	3.64	1,452	320,320
2021-12-06	2021-12-03	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	87,601	2.34	3.63	7,260	317,992
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	85,601	1.18	3.80	3,800	325,284
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	84,601	1.20	3.78	3,780	319,792
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,400	83,601	2.96	3.74	8,976	312,668
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,100	81,201	1.37	3.73	4,103	302,880
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	80,101	1.26	3.71	3,710	297,175
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	79,101	2.59	3.70	7,400	292,674
2021-12-06	2021-12-02	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,601	77,101	2.12	3.69	5,908	284,503
2021-12-02	2021-12-02	4	SVRA	Savara Inc Common Stock	P - Purchase	21,394	1,351,142	1.61	1.09	23,234	1,467,340
2021-12-02	2021-12-01	4	SVRA	Savara Inc Common Stock	P - Purchase	3,606	1,329,748	0.27	1.08	3,894	1,436,128
2021-12-01	2021-12-01	4	SVRA	Savara Inc Common Stock	P - Purchase	9,000	1,326,142	0.68	1.08	9,765	1,438,864
2021-12-01	2021-11-30	4	SVRA	Savara Inc Common Stock	P - Purchase	16,000	1,317,142	1.23	1.09	17,392	1,431,733
2021-11-22	2021-11-22	4	SVRA	Savara Inc Common Stock	P - Purchase	90,000	1,301,142	7.43	1.08	97,020	1,402,631
2021-11-22	2021-11-19	4	SVRA	Savara Inc Common Stock	P - Purchase	49,800	1,211,142	4.29	1.07	53,236	1,294,711
2021-11-22	2021-11-18	4	SVRA	Savara Inc Common Stock	P - Purchase	60,200	1,161,342	5.47	1.08	65,136	1,256,572
2021-11-19	2021-11-17	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	7,500	75,500	11.03	4.23	31,725	319,365
2021-09-30	2021-09-30	4	SVRA	Savara Inc Common Stock	P - Purchase	50,000	1,101,142	4.76	1.30	64,900	1,429,282
2021-09-30	2021-09-29	4	SVRA	Savara Inc Common Stock	P - Purchase	47,500	1,051,142	4.73	1.28	60,658	1,342,308
2021-09-30	2021-09-28	4	SVRA	Savara Inc Common Stock	P - Purchase	39,552	1,003,642	4.10	1.28	50,824	1,289,680
2021-08-19	2021-08-18	4	SVRA	Savara Inc Common Stock	P - Purchase	17,788	964,090	1.88	1.22	21,701	1,176,190
2021-08-19	2021-08-18	4	SVRA	Savara Inc Common Stock	P - Purchase	12,948	946,302	1.39	1.18	15,279	1,116,636
2021-08-19	2021-08-17	4	SVRA	Savara Inc Common Stock	P - Purchase	66,554	933,354	7.68	1.18	78,201	1,096,691
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	600	68,000	0.89	3.60	2,160	244,800
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	400	67,400	0.60	3.57	1,428	240,618
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	67,000	1.52	3.54	3,540	237,180
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	66,000	1.54	3.53	3,530	232,980
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	65,000	3.17	3.52	7,040	228,800
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	63,000	1.61	3.51	3,510	221,130
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	3,000	62,000	5.08	3.50	10,500	217,000
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	59,000	3.51	3.49	6,980	205,910
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	4,000	57,000	7.55	3.48	13,920	198,360
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	53,000	1.92	3.46	3,460	183,380
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	52,000	1.96	3.45	3,450	179,400
2021-05-26	2021-05-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	3,000	51,000	6.25	3.44	10,320	175,440
2021-05-20	2021-05-19	4	SVRA	Savara Inc Common Stock	P - Purchase	5,003	866,800	0.58	1.58	7,905	1,369,544
2021-05-18	2021-05-18	4	SVRA	Savara Inc Common Stock	P - Purchase	50,000	861,797	6.16	1.62	81,100	1,397,835
2021-03-15	2021-03-15	4	SVRA	Savara Inc Common Stock	P - Purchase	689,655	811,797	564.63	1.45	1,000,000	1,177,106
2020-12-17	2020-12-16	4	SVRA	Savara Inc Stock Option (Right to Buy)	A - Award	40,000	40,000
2020-12-14	2020-12-10	4	LJPC	LA JOLLA PHARMACEUTICAL CO Stock Option (Right to Buy)	A - Award	30,000	30,000
2020-09-10	2020-09-08	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	48,000	2.13	3.83	3,830	183,840
2020-08-24	2020-08-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	47,000	2.17	3.73	3,730	175,310
2020-08-24	2020-08-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	46,000	2.22	3.74	3,740	172,040
2020-08-24	2020-08-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	4,000	45,000	9.76	3.75	15,000	168,750
2020-08-24	2020-08-24	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	41,000	2.50	3.82	3,818	156,558
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	5,000	40,000	14.29	4.08	20,400	163,200
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	35,000	6.06	4.04	8,080	141,400
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	33,000	6.45	4.03	8,060	132,990
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	31,000	3.33	4.02	4,020	124,620
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	30,000	7.14	4.01	8,020	120,300
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	28,000	3.70	4.00	4,000	112,000
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	27,000	3.85	3.98	3,980	107,460
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	26,000	4.00	3.97	3,970	103,220
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	25,000	4.17	3.95	3,950	98,750
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	24,000	9.09	3.94	7,888	94,656
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	22,000	4.76	3.93	3,930	86,460
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	21,000	5.00	3.92	3,920	82,320
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	20,000	5.26	3.90	3,900	78,000
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	19,000	5.56	3.88	3,880	73,720
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	18,000	5.88	3.87	3,870	69,660
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	1,000	17,000	6.25	3.86	3,860	65,620
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	16,000	14.29	3.85	7,700	61,600
2020-08-24	2020-08-21	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,000	14,000	16.67	3.84	7,680	53,760
2020-08-24	2020-08-20	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	2,530	12,000	26.72	4.18	10,575	50,160
2020-08-24	2020-08-20	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	3,470	9,470	57.83	4.17	14,470	39,490
2020-08-24	2020-08-20	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	6,000	6,000		4.17	25,015	25,015
2019-12-26	2019-12-20	4	SVRA	Savara Inc Stock Option (Right to Buy)	A - Award	12,000	12,000
2019-12-23	2019-12-20	4	LJPC	LA JOLLA PHARMACEUTICAL CO Stock Option (Right to Buy)	A - Award	12,000	12,000
2019-10-24	2019-10-22	4	LJPC	LA JOLLA PHARMACEUTICAL CO Stock Option (Right to Buy)	A - Award	18,000	18,000
2019-06-28	2019-06-28	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	122,142	4.27	2.36	11,800	288,255
2019-06-28	2019-06-28	4	SVRA	Savara Inc Common Stock	P - Purchase	12,157	117,142	11.58	2.35	28,569	275,284
2019-06-28	2019-06-28	4	SVRA	Savara Inc Common Stock	P - Purchase	18,000	104,985	20.69	2.33	41,940	244,615
2019-06-28	2019-06-27	4	SVRA	Savara Inc Common Stock	P - Purchase	2,300	86,985	2.72	2.38	5,474	207,024
2019-06-28	2019-06-27	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	84,685	6.27	2.39	11,950	202,397
2019-06-28	2019-06-27	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	79,685	6.69	2.40	12,000	191,244
2019-06-28	2019-06-27	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	74,685	7.18	2.42	12,100	180,738
2019-06-28	2019-06-27	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	69,685	7.73	2.45	12,250	170,728
2019-06-28	2019-06-26	4	SVRA	Savara Inc Common Stock	P - Purchase	900	64,685	1.41	2.38	2,142	153,950
2019-06-19	2019-06-18	4	SVRA	Savara Inc Common Stock	P - Purchase	10,215	63,785	19.07	2.35	24,005	149,895
2019-06-19	2019-06-18	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	53,570	10.29	2.36	11,800	126,425
2019-06-19	2019-06-17	4	SVRA	Savara Inc Common Stock	P - Purchase	5,000	48,570	11.48	2.37	11,850	115,111
2019-06-19	2019-06-17	4	SVRA	Savara Inc Common Stock	P - Purchase	10,000	43,570	29.79	2.38	23,800	103,697
2019-06-19	2019-06-17	4	SVRA	Savara Inc Common Stock	P - Purchase	10,000	33,570	42.43	2.39	23,900	80,232
2019-06-19	2017-04-27	4	SVRA	Savara Inc Restricted Stock Units	M - Exercise	-1,142	0	-100.00
2019-06-19	2017-04-27	4	SVRA	Savara Inc Common Stock	M - Exercise	1,142	23,570	5.09
2018-12-14	2018-12-13	4	SVRA	Savara Inc Stock Option (Right to Buy)	A - Award	12,000	12,000
2017-06-09	2017-06-07	4	SVRA	Savara Inc Common Stock	P - Purchase	21,000	22,428	1,470.59	4.75	99,750	106,533
2017-05-26	2017-05-25	4	SVRA	Savara Inc Stock Option (Right to Buy)	A - Award	3,750	3,750
2017-01-23	2017-01-20	4	MSTX	Mast Therapeutics, Inc. Restricted Stock Units	A - Award	79,962	79,962
2016-06-17	2016-06-15	4	MSTX	Mast Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	79,551	79,551
2015-06-12	2015-06-11	4	MSTX	Mast Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	82,963	82,963
2015-02-06	2015-02-06	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	M - Exercise	-7,088	21,262	-25.00
2015-02-06	2015-02-06	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	F - Taxes	-2,660	364,320	-0.72	13.87	-36,894	5,053,118
2015-02-06	2015-02-06	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	7,088	366,980	1.97
2015-02-06	2015-02-04	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	A - Award	28,000	28,000
2015-02-06	2015-02-04	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	A - Award	45,000	45,000
2015-02-04	2015-02-04	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Award	M - Exercise	-2,213	4,424	-33.34
2015-02-04	2015-02-04	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	2,213	359,892	0.62
2015-02-04	2015-02-02	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Award	M - Exercise	-3,125	3,125	-50.00
2015-02-04	2015-02-02	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	3,125	357,679	0.88
2014-12-22	2014-12-22	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	M - Exercise	-17,625	42,594	-29.27
2014-12-22	2014-12-22	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	F - Taxes	-6,621	354,554	-1.83	9.46	-62,635	3,354,081
2014-12-22	2014-12-22	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	17,625	361,175	5.13
2014-12-01	2014-12-01	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	M - Exercise	-20,058	0	-100.00
2014-12-01	2014-12-01	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	20,058	343,550	6.20	2.02	40,517	693,971
2014-09-16	2014-09-16	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	M - Exercise	-50,000	0	-100.00	2.05	-102,500
2014-09-16	2014-09-16	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	P - Purchase	25,000	323,492	8.38	8.90	222,500	2,879,079
2014-09-16	2014-09-16	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	50,000	298,492	20.12	2.05	102,500	611,909
2014-06-20	2014-06-19	4	MSTX	Mast Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	46,609	46,609
2014-02-10	2014-02-06	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	A - Award	28,350	28,350
2014-02-10	2014-02-06	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	A - Award	45,000	45,000		13.10	589,500	589,500
2014-02-04	2014-02-04	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Award	M - Exercise	-2,213	6,637	-25.01
2014-02-04	2014-02-04	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	2,213	248,492	0.90
2014-02-04	2014-02-02	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Award	M - Exercise	-3,125	6,250	-33.33
2014-02-04	2014-02-02	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	3,125	246,279	1.29
2013-12-23	2013-12-20	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	M - Exercise	-10,281	60,219	-14.58
2013-12-23	2013-12-20	4	HALO	HALOZYME THERAPEUTICS INC Common stock	M - Exercise	6,419	243,154	2.71
2013-09-16	2013-09-16	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	M - Exercise	-130,000	0	-100.00	0.39	-50,700
2013-09-16	2013-09-16	4	HALO	HALOZYME THERAPEUTICS INC Common Stock	M - Exercise	130,000	236,735	121.80	0.39	50,700	92,327
2013-06-21	2013-06-19	4	MSTX	Mast Therapeutics, Inc. Stock Option (Right to Buy)	A - Award	62,451	62,451
2013-05-24	2013-05-22	4	HALO	HALOZYME THERAPEUTICS INC Restricted Stock Units	A - Award	70,500	70,500
2013-05-24	2013-05-22	4	HALO	HALOZYME THERAPEUTICS INC Option to Purchase Common Stock	A - Award	117,500	117,500		7.17	842,475	842,475
2013-05-24		3	HALO	HALOZYME THERAPEUTICS INC Common Stock			105,000
2012-07-30	2012-07-28	4	ANX	ADVENTRX PHARMACEUTICALS INC Stock Option (Right to Buy)	A - Award	27,310	27,310
2012-05-14	2012-05-14	4	ANX	ADVENTRX PHARMACEUTICALS INC Common Stock	P - Purchase	50,000	100,000	100.00	0.54	26,965	53,930
2012-05-10	2012-05-10	4	ANX	ADVENTRX PHARMACEUTICALS INC Common Stock	P - Purchase	40,000	50,000	400.00	0.57	22,612	28,265
2012-05-10	2012-05-09	4	ANX	ADVENTRX PHARMACEUTICALS INC Common Stock	P - Purchase	10,000	10,000		0.55	5,500	5,500

非衍生或衍生证券的公开市场或私下买入

非衍生或衍生证券的公开市场或私下卖出

公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）

衍生工具转换

将证券卖出或转让回公司

使用从公司收到的证券的一部分来支付行使价或税务负担。

内部人士赠送或接收他人赠送公司股票

股权掉期和类似的避险交易

行使或转换从公司获得的衍生证券（例如期权）

内部人士通过Form 4自愿报告的一笔交易

其他（附有交易描述的脚注）